TMRAY
Q4 2026 EPS Estimate
$0.08
Oct 23, 2026
Revenue Estimate
$398M
FY2026E EPS$3.68
FY2027E EPS$6.89

Analyst Sentiment

Wall St. Consensus
Buy
1 analyst·Low coverage
75
Score
1 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

No analyst price targets available for TMRAY

Analyst coverage may not be available for this symbol

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+19.74%
EPS+87.55%
FY2028
Rev+8.00%
EPS+13.41%
FY2029
Rev+15.78%
EPS+28.77%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$16.79B$20.10B$21.71B$25.14B
Low$16.54B$17.70B$20.15B$23.33B
High$17.71B$22.35B$23.58B$27.30B
EBITDA Avg$2.95B$3.54B$3.82B$4.42B
Low$2.91B$3.11B$3.55B$4.11B
High$3.12B$3.93B$4.15B$4.81B
EBIT Avg$1.93B$2.31B$2.50B$2.89B
Low$1.90B$2.04B$2.32B$2.68B
High$2.04B$2.57B$2.71B$3.14B
Net Income Avg$1.22B$2.29B$2.60B$3.34B
Low$1.11B$2.08B$2.36B$3.03B
High$1.36B$2.55B$2.89B$3.72B
EPS Avg$3.68$6.89$7.82$10.07
Low$3.33$6.25$7.09$9.13
High$4.09$7.67$8.69$11.19
Analysts (Rev / EPS)8 / 18 / 15 / 16 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$3.93B$4.45B$4.96B$5.25B$310M$294M
Low$3.87B$4.41B$4.90B$5.19B$306M$290M
High$3.99B$4.50B$5.02B$5.32B$314M$298M
EBITDA Avg$692M$783M$873M$924M$55M$52M
Low$681M$776M$862M$913M$54M$51M
High$702M$792M$884M$936M$55M$52M
EBIT Avg$452M$512M$570M$604M$36M$34M
Low$445M$507M$563M$597M$35M$33M
High$459M$517M$577M$612M$36M$34M
Net Income Avg$235M$411M$346M$457M$564M$672M
Low$231M$405M$340M$449M$555M$661M
High$239M$418M$352M$464M$573M$683M
EPS Avg$0.84$1.47$1.24$1.63$2.01$2.40
Low$0.83$1.45$1.22$1.60$1.98$2.36
High$0.85$1.49$1.26$1.66$2.05$2.44
Analysts (Rev / EPS)4 / 14 / 12 / 12 / 12 / 12 / 1

Earnings Surprises

Recent Analyst Actions

No recent analyst actions

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.